• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于机器学习对美国普通人群中N末端脑钠肽前体升高情况的预测

Machine learning-based prediction of elevated N terminal pro brain natriuretic peptide among US general population.

作者信息

Mori Yuichiro, Fukuma Shingo, Yamaji Kyohei, Mizuno Atsushi, Kondo Naoki, Inoue Kosuke

机构信息

Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

出版信息

ESC Heart Fail. 2025 Apr;12(2):859-868. doi: 10.1002/ehf2.15056. Epub 2024 Nov 19.

DOI:10.1002/ehf2.15056
PMID:39558857
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11911594/
Abstract

AIMS

Natriuretic peptide-based pre-heart failure screening has been proposed in recent guidelines. However, an effective strategy to identify screening targets from the general population, more than half of which are at risk for heart failure or pre-heart failure, has not been well established. This study evaluated the performance of machine learning prediction models for predicting elevated N terminal pro brain natriuretic peptide (NT-proBNP) levels in the US general population.

METHODS AND RESULTS

Individuals aged 20-79 years without cardiovascular disease from the nationally representative National Health and Nutrition Examination Survey 1999-2004 were included. Six prediction models (two conventional regression models and four machine learning models) were trained with the 1999-2002 cohort to predict elevated NT-proBNP levels (>125 pg/mL) using demographic, lifestyle, and commonly measured biochemical data. The model performance was tested using the 2003-2004 cohort. Of the 10 237 individuals, 1510 (14.8%) had NT-proBNP levels >125 pg/mL. The highest area under the receiver operating characteristic curve (AUC) was observed in SuperLearner (AUC [95% CI] = 0.862 [0.847-0.878], P < 0.001 compared with the logistic regression model). The logistic regression model with splines showed a comparable performance (AUC [95% CI] = 0.857 [0.841-0.874], P = 0.08). Age, albumin level, haemoglobin level, sex, estimated glomerular filtration rate, and systolic blood pressure were the most important predictors. We found a similar prediction performance even after excluding socio-economic information (marital status, family income, and education status) from the prediction models. When we used different thresholds for elevated NT-proBNP, the AUC (95% CI) in the SuperLearner models 0.846 (0.830-0.861) for NT-proBNP > 100 pg/mL and 0.866 (0.849-0.884) for NT-proBNP > 150 pg/mL.

CONCLUSIONS

Using nationally representative data from the United States, both logistic regression and machine learning models well predicted elevated NT-proBNP. The predictive performance remained consistent even when the models incorporated only commonly available variables in daily clinical practice. Prediction models using regularly measured information would serve as a potentially useful tools for clinicians to effectively identify targets of natriuretic-peptide screening.

摘要

目的

近期指南中提出了基于利钠肽的心力衰竭前期筛查方法。然而,尚未建立一种从普通人群中识别筛查目标的有效策略,其中超过一半的人有心力衰竭或心力衰竭前期风险。本研究评估了机器学习预测模型在美国普通人群中预测N末端脑钠肽前体(NT-proBNP)水平升高的性能。

方法和结果

纳入了来自具有全国代表性的1999 - 2004年国家健康和营养检查调查中年龄在20 - 79岁且无心血管疾病的个体。使用1999 - 2002年队列训练了六个预测模型(两个传统回归模型和四个机器学习模型),以使用人口统计学、生活方式和常用的生化数据预测NT-proBNP水平升高(>125 pg/mL)。使用2003 - 2004年队列测试模型性能。在10237名个体中,1510名(14.8%)的NT-proBNP水平>125 pg/mL。在超级学习者模型中观察到最高的受试者工作特征曲线下面积(AUC)(AUC [95% CI] = 0.862 [0.847 - 0.878],与逻辑回归模型相比,P < 0.001)。带有样条的逻辑回归模型表现相当(AUC [95% CI] = 0.857 [0.841 - 0.874],P = 0.08)。年龄、白蛋白水平、血红蛋白水平、性别、估计肾小球滤过率和收缩压是最重要的预测因素。即使从预测模型中排除社会经济信息(婚姻状况、家庭收入和教育状况),我们也发现了相似的预测性能。当我们对NT-proBNP升高使用不同阈值时,超级学习者模型中NT-proBNP > 100 pg/mL时的AUC(95% CI)为0.846(0.830 - 0.861),NT-proBNP > 150 pg/mL时为0.866(0.849 - 0.884)。

结论

使用来自美国的具有全国代表性的数据,逻辑回归和机器学习模型都能很好地预测NT-proBNP升高。即使模型仅纳入日常临床实践中常用的变量,预测性能仍然一致。使用定期测量信息的预测模型可能会成为临床医生有效识别利钠肽筛查目标的有用工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9646/11911594/5e044ef1d48f/EHF2-12-859-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9646/11911594/07a144373bed/EHF2-12-859-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9646/11911594/97781c12e3aa/EHF2-12-859-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9646/11911594/5e044ef1d48f/EHF2-12-859-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9646/11911594/07a144373bed/EHF2-12-859-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9646/11911594/97781c12e3aa/EHF2-12-859-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9646/11911594/5e044ef1d48f/EHF2-12-859-g002.jpg

相似文献

1
Machine learning-based prediction of elevated N terminal pro brain natriuretic peptide among US general population.基于机器学习对美国普通人群中N末端脑钠肽前体升高情况的预测
ESC Heart Fail. 2025 Apr;12(2):859-868. doi: 10.1002/ehf2.15056. Epub 2024 Nov 19.
2
Brain natriuretic peptide and N-terminal brain natriuretic peptide for the diagnosis of haemodynamically significant patent ductus arteriosus in preterm neonates.脑利钠肽和 N 末端脑利钠肽在诊断早产儿血液动力学意义未闭动脉导管中的应用。
Cochrane Database Syst Rev. 2022 Dec 8;12(12):CD013129. doi: 10.1002/14651858.CD013129.pub2.
3
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
4
NT-proBNP improves prediction of cardiorenal complications in type 2 diabetes: the Hong Kong Diabetes Biobank.N末端B型利钠肽原改善2型糖尿病心肾并发症的预测:香港糖尿病生物样本库
Diabetologia. 2025 Feb;68(2):342-356. doi: 10.1007/s00125-024-06299-x. Epub 2024 Nov 7.
5
Validation of N-Terminal Pro B-Type Natriuretic Peptide Threshold for Early Detection of Pre-Heart Failure in a General Japanese Population - Toon Health Study.N 端前体 B 型利钠肽阈值在日本普通人群中早期检测心力衰竭前期的验证——Toon 健康研究
Circ J. 2025 Jun 25;89(7):966-972. doi: 10.1253/circj.CJ-24-0774. Epub 2025 May 8.
6
Evidence-Based Application of Natriuretic Peptides in the Evaluation of Chronic Heart Failure With Preserved Ejection Fraction in the Ambulatory Outpatient Setting.利钠肽在门诊环境中评估射血分数保留的慢性心力衰竭中的循证应用
Circulation. 2025 Apr 8;151(14):976-989. doi: 10.1161/CIRCULATIONAHA.124.072156. Epub 2025 Jan 22.
7
Determining kidney function-specific thresholds for N-terminal pro-B-type natriuretic peptide in heart failure risk prediction among patients with chronic kidney disease: a multicentre, observational, cohort study.
Heart. 2025 Aug 12;111(17):828-834. doi: 10.1136/heartjnl-2024-324679.
8
Clinical Performance of an N-Terminal Pro-B-Type Natriuretic Peptide Assay in Acute Heart Failure Diagnosis.N 末端前 B 型利钠肽检测在急性心力衰竭诊断中的临床性能
J Appl Lab Med. 2025 Mar 3;10(2):325-338. doi: 10.1093/jalm/jfae107.
9
Amino-Terminal Pro-B-Type Natriuretic Peptide for Diagnosis and Prognosis in Patients With Renal Dysfunction: A Systematic Review and Meta-Analysis.氨基末端前B型利钠肽在肾功能不全患者诊断和预后评估中的应用:一项系统评价和Meta分析
JACC Heart Fail. 2015 Dec;3(12):977-89. doi: 10.1016/j.jchf.2015.07.014.
10
Clinical value of combined detection of serum ferritin and N-terminal pro-brain natriuretic peptide in the assessment of Kawasaki disease in children over 1 year of age.血清铁蛋白与N末端脑钠肽前体联合检测在1岁以上儿童川崎病评估中的临床价值
Ital J Pediatr. 2025 Jul 15;51(1):229. doi: 10.1186/s13052-025-02076-7.

引用本文的文献

1
The effects of moxibustion in chronic heart failure patients: a systematic review and meta-analysis.艾灸对慢性心力衰竭患者的影响:一项系统评价与荟萃分析。
Front Cardiovasc Med. 2025 Jul 15;12:1552091. doi: 10.3389/fcvm.2025.1552091. eCollection 2025.
2
Cardiometabolic Index is associated with heart failure: a cross-sectional study based on NHANES.心脏代谢指数与心力衰竭相关:一项基于美国国家健康与营养检查调查(NHANES)的横断面研究。
Front Med (Lausanne). 2024 Dec 9;11:1507100. doi: 10.3389/fmed.2024.1507100. eCollection 2024.

本文引用的文献

1
BNP and NT-proBNP Thresholds for the Assessment of Prognosis in Patients Without Heart Failure.用于评估无心力衰竭患者预后的BNP和NT-proBNP阈值
JACC Adv. 2023 Nov 16;2(10):100688. doi: 10.1016/j.jacadv.2023.100688. eCollection 2023 Dec.
2
Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: A clinical consensus statement from the Heart Failure Association of the ESC.使用N末端B型利钠肽原(NT-proBNP)进行心力衰竭和心脏应激早期诊断的实用算法:欧洲心脏病学会心力衰竭协会的临床共识声明
Eur J Heart Fail. 2023 Nov;25(11):1891-1898. doi: 10.1002/ejhf.3036. Epub 2023 Sep 26.
3
NT-proBNP and All-Cause and Cardiovascular Mortality in US Adults: A Prospective Cohort Study.
NT-proBNP 与美国成年人全因和心血管死亡率:一项前瞻性队列研究。
J Am Heart Assoc. 2023 Jun 6;12(11):e029110. doi: 10.1161/JAHA.122.029110. Epub 2023 May 26.
4
Elastic Net Regularization Paths for All Generalized Linear Models.所有广义线性模型的弹性网络正则化路径
J Stat Softw. 2023;106. doi: 10.18637/jss.v106.i01. Epub 2023 Mar 23.
5
Effect of Sacubitril/Valsartan vs Valsartan on Left Atrial Volume in Patients With Pre-Heart Failure With Preserved Ejection Fraction: The PARABLE Randomized Clinical Trial.沙库巴曲缬沙坦对比缬沙坦对射血分数保留的心力衰竭前期患者左心房容积的影响:PARABLE 随机临床试验。
JAMA Cardiol. 2023 Apr 1;8(4):366-375. doi: 10.1001/jamacardio.2023.0065.
6
Effect of Nudges to Clinicians, Patients, or Both to Increase Statin Prescribing: A Cluster Randomized Clinical Trial.对临床医生、患者或两者同时采取推动措施以增加他汀类药物处方:一项集群随机临床试验。
JAMA Cardiol. 2023 Jan 1;8(1):23-30. doi: 10.1001/jamacardio.2022.4373.
7
Reference Ranges for NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and Risk Factors for Higher NT-proBNP Concentrations in a Large General Population Cohort.大型普通人群队列中 NT-proBNP(N 端脑利钠肽前体)的参考范围和 NT-proBNP 浓度升高的危险因素。
Circ Heart Fail. 2022 Oct;15(10):e009427. doi: 10.1161/CIRCHEARTFAILURE.121.009427. Epub 2022 Sep 13.
8
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 May 3;145(18):e895-e1032. doi: 10.1161/CIR.0000000000001063. Epub 2022 Apr 1.
9
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.新型基于肌酐和胱抑素 C 的估算肾小球滤过率方程,无需考虑种族因素。
N Engl J Med. 2021 Nov 4;385(19):1737-1749. doi: 10.1056/NEJMoa2102953. Epub 2021 Sep 23.
10
Social Determinants in Machine Learning Cardiovascular Disease Prediction Models: A Systematic Review.机器学习在心血管疾病预测模型中的社会决定因素:系统评价。
Am J Prev Med. 2021 Oct;61(4):596-605. doi: 10.1016/j.amepre.2021.04.016. Epub 2021 Jul 27.